Key result
Aortic valve replacement and bypass grafting for aortic stenosis and coronary artery disease resulted in 4.4% to 5.3% in-hospital mortality, with bioprostheses enhancing late survival.
Why the study?
What are the early and late outcomes of combined aortic valve replacement and coronary bypass grafting in patients with aortic stenosis and coronary artery disease?
Cohort (n=669)
What are the early and late outcomes of combined aortic valve replacement and coronary bypass grafting in patients with aortic stenosis and coronary artery disease?
Answers are grounded in this paper and cite their sources.
Combined aortic valve replacement and coronary bypass grafting can be performed with acceptable early mortality, with bioprostheses potentially enhancing late and event-free survival.
From 1967 to 1981, 294 patients (group A) with aortic stenosis and coronary atherosclerosis underwent aortic valve replacement (AVR) combined with bypass grafting; there were 13 (4.4%) in-hospital deaths. Follow-up of the in-hospital survivors documented late survival of 89%, 79%, and 52% at 2, 5, and 10 postoperative years, respectively. Univariate and multivariate testing identified age greater than or equal to 70 years (P = 0.02) and Class IV symptoms (P = 0.002) as factors decreasing late survival. Patients with bioprostheses who did not take warfarin had the best late survival (P = 0.03) and event-free survival (P = 0.05) and patients with mechanical prostheses who did not take warfarin had the worst (P less than 0.0001) (P = 0.001). From 1981 to 1986, 375 further patients (group B) with aortic stenosis and coronary artery disease underwent AVR and bypass grafting with 20 (5.3%) in-hospital deaths. Group B contained more patients greater than or equal to 70 years (35% vs. 16%) than did group A. Logistic regression analysis identified patients with moderate or severe impairment of left ventricular function and women as sub-groups with increased in-hospital mortality in group B. Patients with aortic stenosis and coronary artery disease can undergo AVR and bypass grafting with a risk slightly increased over that for isolated AVR. Bioprostheses enhance late survival and event-free survival.
No takes yet. Share an insight, caveat, or question.
Lytle et al. (1988) conducted a cohort in Aortic stenosis and coronary artery disease (n=669). Aortic valve replacement and coronary bypass grafting was evaluated on In-hospital mortality and late survival. Aortic valve replacement and bypass grafting for aortic stenosis and coronary artery disease resulted in 4.4% to 5.3% in-hospital mortality, with bioprostheses enhancing late survival.
Synapse has enriched 10 related papers. Consider them for comparative context: